FDA Review Modernization Fully Funded
Generics Modernization Effort At US FDA Receives Full Funding Over Two Years
After receiving $25.1m in FY 2019, Congress gave another $1.9m in FY 2020, which appropriators said combined reaches the $27m requested for the FY 2020 budget.
You may also be interested in...
AAM, Upsher-Smith, APhA, and Cigna tell US FDA that packaging requirement will increase manufacturing and drug costs, create reimbursement hurdles and reduce access to medicines. Daiichi-Sankyo supports agency's proposal.
Agency seeks legislative authority to update outdated generic drug labels when the reference product has been withdrawn.
The agency requested a funding increase in part to implement 2018 legislation intended to combat the opioid crisis, but also to support many initiatives in last year's budget request.